Amido and peptido modified enzymatic nucleic acid molecules

Details Amido and peptido modified enzymatic nucleic acid molecules Amido and peptido modified enzymatic nucleic acid molecules

1998-02-10

2000-07-25

Elliott, George C.

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Preparing compound containing saccharide radical

435325, 435375, 536 245, C07H 2100, C12N 506, C12P 1934

Patent

active

060935553

ABSTRACT:
Oligonucleotide comprising a nucleotide base having the formula: ##STR1## wherein B is a nucleotide base or hydrogen; R.sub.1, R.sub.2 and R.sub.3 independently is selected from the group consisting of hydrogen, an alkyl group containing between 2 and 10 carbon atoms inclusive, an amine, an amino acid, and a peptide containing between 2 and 5 amino acids inclusive; and the zigzag lines are independently hydrogen or a bond.

REFERENCES:
patent: 4987071 (1991-01-01), Cech et al.
patent: 5334711 (1994-08-01), Sproat et al.
patent: 5783425 (1998-07-01), Dudycz et al.
Christoffersen et al. "Ribozymes as human therapeutic agents" J. Med. Chem. 38(12): 2023-2037, Jun. 1995.
Ghosh et al. "Use of Maledimide-thiol coupling chemistry for efficient synthesis of oligonucleotide-enzyme conjugate hybridization probes" Bioconjugate Chem. 1(1): 71-77, Jan. 1990.
Gura. "Antisense has growing pains" Science 270: 575-577, Oct. 1995.
Stull et al. "Antigene, ribozyme and aptamer nucleic acid drug design: Progress and prospects" Pharm. Res. 12(4): 465-483, Apr. 1995.
Ballantyne et al., "Nucleotide Sequence of the cDNA for Murine Intercellular Adhesion Molecule-1 (ICAM-1)," Nucleic Acids Research 17:5853 (1989).
Bainaga, "Ribozymes: Killing the Messenger," Science 262:1512:1514 (1993).
Cech, "Ribozymes and Their Medical Implications" JAMA 260:3030-3034 (1988).
Cotten, "The in vivo Application of Ribozymes," TIBTECH 8;174-178 (1990).
Collins et al., "Reaction Conditions and Kinetics of Self-Cleavage of a Riboyme Derived From Neurospora VS RNA," Biochemistry 32:2795-2799 (1993).
Edington, "Ribozymes: Stop Making Sense," Biotechnology 10:256-262 (1992).
Guerrier-Takada et al., " The RNA Moiety of Ribonuclease P Is the Catalytic Subunit of the Enzyme," Cell 35:849-857 (1983).
Hampel et al., "Hairpin' Catalytic RNA Model: Evidence for Helices and Sequence Requirement for Substrate RNA", Nucleic Acids Research 18:299-304 (1990).
Hampel et al., "RNA Catalytic Properties of the Minimum (-)sTRSV Sequence," Biochemistry 28:4929-4933 (1989).
Haralambidis et al., "The Solid Phase Synthesis of Oligonucleotides Containig a 3'- Peptide Moiety," Tetrahedon Lett. 28:5199-5202 (1987).
Haseloff et al., "Simple RNA Enzymes with New and Highly Specific Endoribonuclease Activities," Nature 334-585-591 (1988).
Jeffries et al., "A Catalytic 13-mer Ribozyme," Nucleic Acids Research 17:1371-1377 (1989).
Kim et al., "Three-dimensional Model of the Active Site of the Self-Splicing rRNA Precursor of Tetrahymena," Proc. Natl. Acad. Sci. USA 84:8788-8792 (1987).
Kita et al., "Sequence and Expression of Rat ICAM-1," Biochem. Biophys. Acta 1131:108-110 (1992).
Mag et al., "Synthesis and Selective Cleavage of Oligodeoxyribonucleotides Containing Non-Chiral Internucleotide Phosphormidate Linkages," Nucleic Acids Research 17:5973-5989 (1989).
Perreault et al., "Mixed Deoxyribo- and Ribo-Oligonucleotides with Catalytic Activity," Nature 344:565-567 (1990).
Perrotta et al., "Cleavage of Oligoribonucleotides by a Ribozyme Derived from the Hepatitis .delta. Virus RNA Sequence," Biochemistry 31:16-21 (1992).
Pieken et al., "Kinetic Characterization of Ribonuclease-Resistant 2'-Modified Hammerhead Ribozymes," Science 253:314-317 (1991).
Rossi et al., "Ribozymes as Anti-HIV-1 Therapeutic Agents: Principles, Applictions, and Problems," Aids Research and Human Retroviruses 8:183 (1992).
Saville et al., "A Site-Specific Self-Cleavage Reaction Performed by a Novel RNA In Nuerospora Mitochondria," Cell 61:685-696 (1990).
Saville et al., "RNA-Mediated Ligation of Self-Cleavage Products of a Neurospora Mitochondrial Plasmid Transcript," Proc. Natl. Acad. Sci. USA 88:8826-8830 (1991).
Scaromge et al., "Chemical Synthesis of Biologically Active Oligoribonucleotides using .beta.-cyanoethyl Protected Ribonucleoside Phosphoramidites," Nucl Acids Res. 18:5433-5441 (1990).
Simons et al., "ICAM, an Adhesion Ligand of LFA-1, is Homologour to the Neutral Cell Adhesion Molecule NCAM," Nature 331:624-627 (1989).
Uhlenbeck, "A Small Catalytic Oligoribonucleotide," Nature 328:596-600 (1987).
Uhlmann et al., "Antisense Oligonucleotides: A New Therapeutic Principle," Chem. Rev. 90:542-585 (1990).
Usman et al., "Automated Chemical Synthesis of Long Oligoribonucleotides Using 2'-O-Silylated Ribonucleoside 3'-O-Phosphoramidites on a Controlled-Pore Glass Support: Synthesis of a 43-Nucleotide Sequence Similar to the 3'-Half Molecule of an Escherichia coli Formulmethoionine tRNA," J. Am. Chem. Soc. 109:7845-7854 (1987).
Usman et al., "Exploiting the Chemical Synthesis of RNA," TIBS 17:334-339 (1992).

Affiliated with

Also associated with

Rating

Amido and peptido modified enzymatic nucleic acid molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amido and peptido modified enzymatic nucleic acid molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amido and peptido modified enzymatic nucleic acid molecules will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1335493